Rapid early HDV RNA decline in the peripheral blood but prolonged intrahepatic hepatitis delta antigen persistence after liver transplantation

Journal of Hepatology

Volumn 56, Issue 1, 2012, Pages 115-122

  Mederacke, Ingmar ^a   Filmann, Natalie ^b   Yurdaydin, Cihan ^c   Bremer, Birgit ^a   Puls, Florian ^a   Zacher, Behrend Johann ^a   Heidrich, Benjamin ^a   Tillmann, Hans Ludger ^d   Rosenau, Jens ^a   Bock, C Thomas ^e   Savas, Berna ^c   Helfritz, Fabian ^a   Lehner, Frank ^a   Strassburg, Christian P ^a   Klempnauer, Juergen ^a   Wursthorn, Karsten ^a   Lehmann, Ulrich ^a   Manns, Michael P ^a   Herrmann, Eva ^b   Wedemeyer, Heiner ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b GOETHE UNIVERSITY   (Germany)

^c ANKARA UNIVERSITY   (Turkey)

^d DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^e ROBERT KOCH INSTITUTE   (Germany)

Author keywords

HDAg staining; Hepatitis B immunoglobulin (HBIG); Hepatitis delta; Liver transplantation; Mathematical modeling; Prophylaxis of reinfection

Indexed keywords

COMPLEMENTARY DNA; HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS DELTA ANTIGEN; VIRUS DNA; VIRUS RNA;

ADULT; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CHRONIC HEPATITIS; CLINICAL ARTICLE; DELTA AGENT HEPATITIS; FEMALE; HEPATITIS B; HEPATITIS DELTA VIRUS; HUMAN; LIVER BIOPSY; LIVER TRANSPLANTATION; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; VIRION;

ADULT; FEMALE; HEPATITIS B SURFACE ANTIGENS; HEPATITIS D, CHRONIC; HEPATITIS DELTA ANTIGENS; HEPATITIS DELTA VIRUS; HUMANS; LIVER; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; RETROSPECTIVE STUDIES; RNA, VIRAL; TIME FACTORS; VIRUS LATENCY; YOUNG ADULT;

EID: 83555160889     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2011.06.016     Document Type: Article

References (45)

1. H. Wedemeyer, and M.P. Manns Epidemiology, pathogenesis and management of hepatitis D: update and challenges ahead Nat Rev Gastroenterol Hepatol 7 2010 31 40
2. K.S. Wang, Q.L. Choo, A.J. Weiner, J.H. Ou, R.C. Najarian, and R.M. Thayer Structure, sequence and expression of the hepatitis delta (delta) viral genome Nature 323 1986 508 514 (Pubitemid 16025373)
3. J.M. Taylor Hepatitis delta virus Virology 344 2006 71 76 (Pubitemid 41814452)
4. M. Rizzetto The delta agent Hepatology 3 1983 729 737 (Pubitemid 13007702)
5. G. Fattovich, G. Giustina, E. Christensen, M. Pantalena, I. Zagni, and G. Realdi The European concerted action on viral hepatitis (Eurohep) Gut 46 2000 420 426
6. G. Fattovich, S. Boscaro, F. Noventa, E. Pornaro, D. Stenico, and A. Alberti Influence of hepatitis delta virus infection on progression to cirrhosis in chronic hepatitis type B J Infect Dis 155 1987 931 935 (Pubitemid 17062828)
7. P. Farci Delta hepatitis: an update J Hepatol 39 2003 S212 S219
8. A. Erhardt, W. Gerlich, C. Starke, U. Wend, A. Donner, and A. Sagir Treatment of chronic hepatitis delta with pegylated interferon-alpha2b Liver Int 26 2006 805 810 (Pubitemid 44172032)
9. G.A. Niro, A. Ciancio, G.B. Gaeta, A. Smedile, A. Marrone, and A. Olivero Pegylated interferon alpha-2b as monotherapy or in combination with ribavirin in chronic hepatitis delta Hepatology 44 2006 713 720 (Pubitemid 44433728)
10. C. Castelnau, F. Le Gal, M.P. Ripault, E. Gordien, M. Martinot-Peignoux, and N. Boyer Efficacy of peginterferon alpha-2b in chronic hepatitis delta: relevance of quantitative RT-PCR for follow-up Hepatology 44 2006 728 735 (Pubitemid 44433730)
11. G.A. Niro, A. Ciancio, H.L. Tillman, M. Lagget, A. Olivero, and F. Perri Lamivudine therapy in chronic delta hepatitis: a multicentre randomized-controlled pilot study Aliment Pharmacol Ther 22 2005 227 232 (Pubitemid 41153065)
12. C. Yurdaydin, H. Bozkaya, S. Gurel, H.L. Tillmann, N. Aslan, and A. Okcu-Heper Famciclovir treatment of chronic delta hepatitis J Hepatol 37 2002 266 271 (Pubitemid 34833090)
13. C. Yurdaydin, H. Bozkaya, H. Cetinkaya, T. Sahin, D. Karaoguz, and M. Toruner Lamivudine vs lamivudine and interferon combination treatment of HBeAg(-) chronic hepatitis B J Viral Hepat 12 2005 262 268 (Pubitemid 40638033)
14. H. Wedemeyer, C. Yurdaydin, G.N. Dalekos, A. Erhardt, Y. Cakaloglu, and H. Degertekin Peginterferon plus adefovir versus either drug alone for hepatitis delta N Engl J Med 364 2011 322 331
15. M. Rizzetto, E. Chiaberge, F. Negro, C. Digiacomo, R. Cortesini, and M. Doglia Liver-transplantation in hepatitis-delta virus-disease Lancet 2 1987 469 471
16. D. Samuel, R. Muller, G. Alexander, L. Fassati, B. Ducot, and J.P. Benhamou Liver transplantation in European patients with the hepatitis B surface antigen N Engl J Med 329 1993 1842 1847 (Pubitemid 23360483)
17. K. Wursthorn, H. Wedemeyer, and M.P. Manns Managing HBV in patients with impaired immunity Gut 59 2010 1430 1445
18. J. Rosenau, T. Kreutz, M. Kujawa, M.J. Bahr, K. Rifai, and N. Hooman HBsAg level at time of liver transplantation determines HBsAg decrease and anti-HBs increase and affects HBV DNA decrease during early immunoglobulin administration J Hepatol 46 2007 635 644 (Pubitemid 46400147)
19. European Association For The Study Of The Liver EASL Clinical Practice Guidelines: management of chronic hepatitis B J Hepatol 50 2009 227 242
20. B. Roche, and D. Samuel Liver transplantation in viral hepatitis: prevention of recurrence Best Pract Res Clin Gastroenterol 22 2008 1153 1169
21. A. Ottobrelli, A. Marzano, A. Smedile, S. Recchia, M. Salizzoni, and C. Cornu Patterns of hepatitis delta-virus reinfection and disease in liver-transplantation Gastroenterology 101 1991 1649 1655
22. D. Samuel, A.L. Zignego, M. Reynes, C. Feray, J.L. Arulnaden, and M.F. David Long-term clinical and virological outcome after liver transplantation for cirrhosis caused by chronic delta hepatitis Hepatology 21 1995 333 339
23. M.R. Lucey, D.M. Graham, P. Martin, A. Di Bisceglie, S. Rosenthal, and J.G. Waggoner Recurrence of hepatitis B and delta hepatitis after orthotopic liver transplantation Gut 33 1992 1390 1396
24. E. David, J. Rahier, A. Pucci, P. Camby, M. Scevens, and M. Salizzoni Recurrence of hepatitis D (delta) in liver transplants: histopathological aspects Gastroenterology 104 1993 1122 1128 (Pubitemid 23090766)
25. S.E. Davies, J.Y. Lau, J.G. O'Grady, B.C. Portmann, G.J. Alexander, and R. Williams Evidence that hepatitis D virus needs hepatitis B virus to cause hepatocellular damage Am J Clin Pathol 98 1992 554 558
26. E.J. Gane, P.W. Angus, S. Strasser, D.H.G. Crawford, J. Ring, and G.P. Jeffrey Lamivudine plus low-dose hepatitis B immunoglobulin to prevent recurrent hepatitis B following liver transplantation Gastroenterology 132 2007 931 937 (Pubitemid 46440868)
27. J. Ahn, S.F. Dodson, and S.M. Cohen Oral antiviral therapy without long term maintenance hepatitis B immunoglobulin to prevent hepatitis B recurrence in liver transplant patients J Hepatol 48 2008 S73 S74
28. I. Lenci, G. Tisone, D. Di Paolo, F. Marcuccilli, L. Tariciotti, and M. Ciotti Withdrawal of prophylaxis against Hbv in transplanted patients with undetectable intrahepatic total and Ccc-Dna: clinical outcome after twenty months of follow-up J Hepatol 52 2010 S194
29. L. Teperman, J. Spivey, F. Poordad, T. Schiano, N. Bzowej, and S. Pungpapong Emtricitabine tenofovir Df combination plus/-Hbig post-orthotopic liver transplantation to prevent hepatitis B recurrence in patients with normal to moderate renal impairment: interim results J Hepatol 52 2010 S12 S13
30. K.A. Powers, R.M. Ribeiro, K. Patel, S. Pianko, L. Nyberg, and P. Pockros Kinetics of hepatitis C virus reinfection after liver transplantation Liver transpl 12 2006 207 216 (Pubitemid 43273778)
31. H. Dahari, A. Feliu, M. Garcia-Retortillo, X. Forns, and A.U. Neumann Second hepatitis C replication compartment indicated by viral dynamics during liver transplantation J Hepatol 42 2005 491 498 (Pubitemid 40342927)
32. M. Garcia-Retortillo, X. Forns, A. Feliu, E. Moitinho, J. Costa, and M. Navasa Hepatitis C virus kinetics during and immediately after liver transplantation Hepatology 35 2002 680 687 (Pubitemid 34183974)
33. J. Rosenau, M.J. Bahr, H.L. Tillmann, C. Trautwein, J. Klempnauer, and M.P. Manns Lamivudine and low-dose hepatitis B immune globulin for prophylaxis of hepatitis B reinfection after liver transplantation possible role of mutations in the YMDD motif prior to transplantation as a risk factor for reinfection J Hepatol 34 2001 895 902 (Pubitemid 32595190)
34. I. Mederacke, B. Bremer, B. Heidrich, J. Kirschner, K. Deterding, and T. Bock Establishment of a novel quantitative HDV RNA assay using the COBAS TaqMan platform to study HDV RNA kinetics J Clin Microbiol 2010
35. N.L. Toan, L.H. Song, P.G. Kremsner, D.N. Duy, V.Q. Binh, and B. Koeberlein Impact of the hepatitis B virus genotype and genotype mixtures on the course of liver disease in Vietnam Hepatology 43 2006 1375 1384 (Pubitemid 43982515)
36. J. Jaroszewicz, S.B. Calle, K. Wursthorn, K. Deterding, J. Schlue, and R. Raupach Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: a European perspective J Hepatol 52 2010 514 522
37. A.U. Neumann, N.P. Lam, H. Dahari, D.R. Gretch, T.E. Wiley, and T.J. Layden Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy Science 282 1998 103 107 (Pubitemid 28471138)
38. R.C. Dickson, N.A. Terrault, M. Ishitani, K.R. Reddy, P. Sheiner, and V. Luketic Protective antibody levels and dose requirements for IV 5% Nabi Hepatitis B immune globulin combined with lamivudine in liver transplantation for hepatitis B-induced end stage liver disease Liver transpl 12 2006 124 133
39. R.W. McGory, M.B. Ishitani, W.M. Oliveira, W.C. Stevenson, C.S. McCullough, and R.C. Dickson Improved outcome of orthotopic liver transplantation for chronic hepatitis B cirrhosis with aggressive passive immunization Transplantation 61 1996 1358 1364 (Pubitemid 26152826)
40. R. Adler, R. Safadi, Y. Caraco, M. Rowe, A. Etzioni, and Y. Ashur Comparison of immune reactivity and pharmacokinetics of two hepatitis B immune globulins in patients after liver transplantation Hepatology 29 1999 1299 1305 (Pubitemid 29168768)
41. N. Hooman, K. Rifai, J. Hadem, B. Vaske, G. Philipp, and A. Priess Antibody to hepatitis B surface antigen trough levels and half-lives do not differ after intravenous and intramuscular hepatitis B immunoglobulin administration after liver transplantation Liver transpl 14 2008 435 442 (Pubitemid 351524398)
42. A. Smedile, J.L. Casey, P.J. Cote, M. Durazzo, B. Lavezzo, and R.H. Purcell Hepatitis D viremia following orthotopic liver transplantation involves a typical HDV virion with a hepatitis B surface antigen envelope Hepatology 27 1998 1723 1729 (Pubitemid 28264701)
43. H.J. Netter, J.L. Gerin, B.C. Tennant, and J.M. Taylor Apparent helper-independent infection of woodchucks by hepatitis-delta virus and subsequent rescue with woodchuck hepatitis-virus J Virol 68 1994 5344 5350 (Pubitemid 24258546)
44. U. Hopf, P. Neuhaus, H. Lobeck, V. Konig, S. Kuther, and J. Bauditz Follow-up of recurrent hepatitis B and delta infection in liver allograft recipients after treatment with recombinant interferon-alpha J Hepatol 13 1991 339 346
45. I. Mederacke, M. Meier, J.B. Luth, H. Schmidt-Gurtler, R. Raupach, and R. Horn-Wichmann Different kinetics of HBV and HCV during haemodialysis and absence of seronegative viral hepatitis in patients with end-stage renal disease Nephrol Dial Transplant 26 2011 2648 2656